Igm Biosciences Stock Probability of Future Stock Price Finishing Under 0.14
| IGMS Stock | USD 9.46 0.06 0.64% |
IGM |
IGM Biosciences Target Price Odds to finish below 0.14
The tendency of IGM Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.14 or more in 90 days |
| 9.46 | 90 days | 0.14 | near 1 |
Based on a normal probability distribution, the odds of IGM Biosciences to drop to $ 0.14 or more in 90 days from now is near 1 (This IGM Biosciences probability density function shows the probability of IGM Stock to fall within a particular range of prices over 90 days) . Probability of IGM Biosciences price to stay between $ 0.14 and its current price of $9.46 at the end of the 90-day period is about 7.58 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.15 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, IGM Biosciences will likely underperform. Additionally IGM Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. IGM Biosciences Price Density |
| Price |
Predictive Modules for IGM Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IGM Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.IGM Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IGM Biosciences is not an exception. The market had few large corrections towards the IGM Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IGM Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IGM Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 2.15 | |
σ | Overall volatility | 2.93 | |
Ir | Information ratio | -0.0051 |
IGM Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IGM Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IGM Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IGM Biosciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.13 M. Net Loss for the year was (246.42 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| IGM Biosciences currently holds about 469.14 M in cash with (192.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| IGM Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: IGM Biosciences Price Target Raised to 27.00 |
IGM Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IGM Stock often depends not only on the future outlook of the current and potential IGM Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IGM Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.3 M | |
| Cash And Short Term Investments | 337.7 M |
IGM Biosciences Technical Analysis
IGM Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. IGM Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of IGM Biosciences. In general, you should focus on analyzing IGM Stock price patterns and their correlations with different microeconomic environments and drivers.
IGM Biosciences Predictive Forecast Models
IGM Biosciences' time-series forecasting models is one of many IGM Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IGM Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about IGM Biosciences
Checking the ongoing alerts about IGM Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for IGM Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| IGM Biosciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.13 M. Net Loss for the year was (246.42 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| IGM Biosciences currently holds about 469.14 M in cash with (192.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| IGM Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: IGM Biosciences Price Target Raised to 27.00 |
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.